<DOC>
	<DOCNO>NCT01711619</DOCNO>
	<brief_summary>The purpose study compare effectiveness peripheral nerve stimulation utilize subcutaneous lead implant technique ( SQS ) plus optimized medical management ( OMM ) versus OMM alone patient suffer back pain due Failed Back Surgery Syndrome ( FBSS ) .</brief_summary>
	<brief_title>SubQStim : A Post-market Study Subcutaneous Nerve Stimulation Failed Back Surgery Syndrome ( FBSS ) Patients</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Failed Back Surgery Syndrome</mesh_term>
	<criteria>1 . Provides write Patient Informed Consent/Patient Information Sheet prior studyrelated activity conduct 2 . â‰¥ 18 year age time inform consent 3 . Willing available attend visit schedule comply study protocol 4 . Willing able undergo assessment part evaluation eligibility endpoints 5 . Willing able use external neurostimulator , recharge equipment ( applicable ) , patient programmer per schedule require protocol 6 . Diagnosed FBSS ( i.e . ) : Has persistent pain 6 month follow recent anatomically correct , successful surgery AND There therapeutic surgical option available assessed appropriate investigation 7 . Back pain consider intractable adequately treat ( failed appropriate trial least 3 different class back pain treatment ( pharmaceutical and/or nonpharmaceutical ) ) 8 . Is appropriate implant candidate SQS system 1 . Has currently treat spinal cord stimulation , subcutaneous nerve stimulation , peripheral nerve stimulation implantable intrathecal drug delivery system 2 . Evidence active disruptive psychiatric disorder significant enough impact perception pain , compliance intervention and/or ability evaluate treatment outcome , determine investigator 3 . Has pain condition unrelated FBSS severe enough overshadow FBSS pain opinion investigator 4 . Spinal instability anatomic compression require surgery 5 . Spinal fusion 3 vertebral level 6 . Currently enrol plan enroll concurrent drug and/or device study may confound result study 7 . Allergic show hypersensitivity material device system come contact body 8 . History coagulation disorder lupus erythematosus 9 . Involved current litigation regard back pain</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>